Welcome to LookChem.com Sign In|Join Free

CAS

  • or

114077-82-6

Post Buying Request

114077-82-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

114077-82-6 Usage

Chemical Properties

White to light yellow powder

Check Digit Verification of cas no

The CAS Registry Mumber 114077-82-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,0,7 and 7 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 114077-82:
(8*1)+(7*1)+(6*4)+(5*0)+(4*7)+(3*7)+(2*8)+(1*2)=106
106 % 10 = 6
So 114077-82-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H4ClNO/c7-6-1-2-8-3-5(6)4-9/h1-4H

114077-82-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chloropyridine-3-carboxaldehyde

1.2 Other means of identification

Product number -
Other names 4-Chloro-3-pyridinecarboxaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:114077-82-6 SDS

114077-82-6Relevant articles and documents

Aromatizing olefin metathesis by ligand isolation inside a metal- organic framework

Vermeulen, Nicolaas A.,Karagiaridi, Olga,Sarjeant, Amy A.,Stern, Charlotte L.,Hupp, Joseph T.,Farha, Omar K.,Stoddart, J. Fraser

, p. 14916 - 14919 (2013)

The aromatizing ring-closing metathesis has been shown to take place inside an extended porous framework. Employing a combination of solvent-assisted linker exchange and postsynthesis modification using olefin metathesis, the noninterpenetrated SALEM-14 was formed and converted catalytically into PAH-MOF-1 with polycyclic aromatic hydrocarbon (PAH) pillars. The metal-organic framework in SALEM-14 prevents "intermolecular" olefin metathesis from occurring between the pillars in the presence of the first generation Hoveyda-Grubbs catalyst, while favoring the production of a PAH, which can be released from the framework under acidic conditions in dimethylsulfoxide.

NOVEL PYRAZOLE DERIVATIVE AS ALK5 INHIBITOR AND USES THEREOF

-

, (2019/05/16)

The present disclosure relates to a novel substituted pyrazole derivative having an effect of inhibiting serine/threonine kinase activity targeting receptor ALK5 of TGF-β, and a pharmaceutical composition including the compound of the present disclosure as an active ingredient may be useful in preventing and/or treating cancers, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, pulmonary diseases, cardiovascular diseases or metabolic diseases, or other diseases associated with a decrease in TGF family signaling activity.

A 3 - aldehyde -4 - chloro pyridine green preparation method

-

Paragraph 0027-0032, (2019/03/25)

The invention discloses a 3 - aldehyde - 4 - chloro pyridine green preparation method, which belongs to the technical field of organic synthesis. Technical proposal of the invention points are: to pyridine as raw materials, the selective chlorination, after the adoption of the salt in the solvent impurities and product of different solubility, can be recrystallized separation, to obtain 4 - chloro pyridine pure product, finally is then subjected to an N, N - dimethyl formamide substitution reaction to obtain the 3 - aldehyde - 4 - chloro pyridine. The invention compared with the prior art has the following advantages: the invention synthetic method is simple, cheap price of raw materials, and is favorable for industrial production.

HETEROAROMATIC ELECTROPHILES AND METHODS OF USING THEREOF

-

Page/Page column 50; 51, (2018/09/18)

Disclosed herein are compounds, compositions, and methods for reactivating or realkylating aged acetylcholinesterase inhibited by or conjugated to the organophosphorus compound. The organophosphorus compound can be a nerve agent. The acetylcholinesterase can be in the central nerve system (CNS) and/or the peripheral nervous system (PNS) of a subject. Accordingly, methods for ameliorating, diminishing, reversing, treating or preventing the toxic effects of an organophosphorus compound in a subject are provided herein. Methods for prophylactic or therapeutic treatment of exposure to an organophosphorus nerve agent are also provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 114077-82-6